Frequencies of epigenetic reductions of nine other DNA repair genes have been evaluated in various cancers and range from 2% (OGG1 in papillary thyroid cancer) to 88% and 90% (MGMT in gastric and colon cancers, respectively).
As frecuencias das reducións epixenéticas doutros nove xenes de reparación do ADN foron avaliadas en varios cancros e ían desde o 2% (OGG1 no cancro de tiroide papilar) ao 88% e 90% (MGMT en cancros gástricos e de colon, respectivamente).